or Try an Advanced Search...

    Genetic Diseases Stocks List

    Symbol Grade Name % Change
    LUMO A Lumos Pharma, Inc. -1.58
    NTRA B Natera, Inc. 2.65
    LRMR C Larimar Therapeutics, Inc. -5.90
    KRYS C Krystal Biotech, Inc. 2.24
    BPMC C Blueprint Medicines Corporation 3.65
    STOK C Stoke Therapeutics, Inc. 4.05
    ADVM D Adverum Biotechnologies, Inc. 1.58
    SYBX F Synlogic, Inc. 1.39
    INZY F Inozyme Pharma, Inc. 1.63
    CODX F Co-Diagnostics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biotechnology Disease Rare Genetic Disease Biopharmaceutical Clinical Medicine Medicine Rare Genetic Diseases Acid Biology Cancer Gene Therapy Life Sciences Medical Test Pharmacy Rare Diseases Severe Genetic Diseases Adverum Biotechnologies Applied Genetics Ataxia Cell Biology

    Related ETFs - A few ETFs which own one or more of the above listed Genetic Diseases stocks.

    Symbol Grade Name Weight
    WDNA D WisdomTree BioRevolution Fund 1.16
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 0.54
    BMED C BlackRock Future Health ETF 0.52
    XBI B SPDR S&P Biotech ETF 0.15
    IWC B iShares Microcap ETF 0.14
    View all Genetic Diseases ETFs...
    Compare ETFs
    Compare BMED to XBI Compare WDNA to IWC Compare WDNA to XBI

        Genetic Diseases Stocks Recent News

        Date Stock Title
        Nov 1 BPMC High Growth Tech Stocks to Watch in November 2024
        Nov 1 STOK Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
        Nov 1 BPMC Blueprint Medicines Third Quarter 2024 Earnings: EPS Beats Expectations
        Nov 1 NTRA Natera to Report its Third Quarter 2024 Results on November 12, 2024
        Nov 1 KRYS Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock?
        Oct 31 NTRA Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
        Oct 31 CODX Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans?
        Oct 31 BPMC BPMC Beats on Q3 Earnings and Sales, Raises '24 View, Stock Up
        Oct 31 BPMC Blueprint Medicines Corp (BPMC) Q3 2024 Earnings Call Highlights: Record AYVAKIT Revenue and ...
        Oct 31 BPMC Q3 2024 Blueprint Medicines Corp Earnings Call
        Oct 30 BPMC Blueprint Medicines Corporation (BPMC) Q3 2024 Earnings Call Transcript
        Oct 30 BPMC Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 LRMR Larimar Therapeutics GAAP EPS of -$0.24 beats by $0.14
        Oct 30 NTRA Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term
        Oct 30 BPMC Blueprint Medicines: Q3 Earnings Snapshot
        Oct 30 BPMC Blueprint Medicines beats Q3 top and bottom-line estimates
        Oct 30 BPMC Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
        Oct 30 LRMR Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
        Oct 29 BPMC Blueprint Medicines Q3 2024 Earnings Preview
        Oct 29 STOK Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biotechnology Black Diamond Cancer Cancer Treatment Diamond Disease Enzymes Epidermal Growth Factor Receptor Epigenetics Kinase Oncogenes Precision Medicine Protein Kinase Proteins Rare Genetic Disease Rare Genetic Diseases Severe Genetic Diseases Therapies For Cancer Tyrosine Kinase Receptors
        Genetic Diseases

        Genetic diseases are disorders caused by changes in genes or chromosomes. These changes can be inherited from a parent or acquired during a person's lifetime. Examples of genetic diseases include cystic fibrosis, sickle cell anemia, and Huntington's disease.

        Browse All Tags